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Introduction: Renal involvement in POEMS (polyneuropathy, organomegaly, endocrinopathy, M-band, skin
changes) syndrome is considered to be an under-diagnosed phenomenon with no clear treatment path. The
limited literature suggests steroids to be the drug of choice, although improvements are limited and usually
reverse on withdrawal of the drug.
Case presentation: A 52-year-old Caucasian woman presenting with features consistent with POEMS syndrome
developed progressive renal impairment with proteinuria. Renal biopsy revealed a membranoproliferative
glomerulonephritis. She was treated with relatively low dose oral mycophenolate mofetil and prednisolone which
stabilised her nephropathy and neuropathy.
Conclusion: We describe an alternative therapeutic option in patients with this serious but poorly understood
condition.
Introduction
POEMS (polyneuropathy, organomegaly, endocrinopa-
thy, M-band, skin changes) syndrome was first described
by Nakanishi et al. [1] in Japan where it is known as
Crow-Fakuse syndrome. A diagnosis of POEMS syn-
drome can be made if patients exhibit major criteria
consisting of polyneuropathy and monoclonal plasmo-
proliferative disorder in conjunction with at least one
minor criterion from sclerotic bone lesions, Castleman
disease, organomegaly, oedema, endocrinopathy, skin
changes and papilloedema [2]. However, others have
suggested that all these diagnostic criteria are not always
evident [3,4].
Renal involvement in POEMS syndrome is recognised,
but incidence is uncertain. An early report by Driedger
and Pruzanski [5] suggested that 50% of patients
demonstrated elevated blood urea nitrogen (BUN) or
proteinuria, whereas Navis et al. [6] found that, of 200
patients with POEMS, only 21 had evidence of renal
involvement.
Nakamoto et al. [7] reviewed 52 cases of Japanese
patients with nephropathy. All patients manifested four
or all of the five signs of POEMS. Polyneuropathy was
present in all but one patient. A majority of cases had
monoclonal protein in blood (either IgA- or IgG-)
although 10 demonstrated a polyclonal hypergammaglo-
bulinaemia, but in these, four other signs of POEMS
supported the diagnosis. Additional signs included papil-
loedema, serositis with massive fluid retention, leg
oedema, clubbed fingers, and cutaneous angiomas. Iso-
lated plasmacytoma was present in four patients, and
lesions in the remaining patients, if present, were of the
osteosclerotic type. Castleman-like lymphoma was
observed in nine patients. The median age of the
patients was 49 years (range 28-75 years) and there was
a roughly equal sex distribution. Nearly half of the * Correspondence: garethrosser@hotmail.com
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(5-168 months).
Most patients demonstrated low-level proteinuria (up
to 2 g/day), but no patient was at the nephrotic level.
Microscopic haematuria was seen in less than one-third.
Blood pressure (BP) was generally normotensive (<140/
90 mmHg) or hypotensive even at the uraemic stage.
Half the patients had significant renal impairment,
defined as a serum creatinine level above 1.5 mg/dl and
20% eventually required renal replacement therapy. The
blood urea to creatinine ratio was frequently elevated,
which would be consistent with a pre-renal element to
the renal impairment, which was thought to stem from
volume contraction.
The majority of patients demonstrated membranopro-
liferative glomerulonephritis (MPGN)-like lesions as ori-
ginally described by Sano et al. [8], characterised by
marked glomerular enlargement and cellular prolifera-
tion. Some demonstrated an endarteritis of small
arteries, which was unrelated to hypertension, and
appeared to contribute to progressive renal damage,
eventually resulting in bilateral or unilateral kidney con-
traction. A third of patients showed non-specific immu-
nofluorescent staining for immunoglobulin heavy and
light chains.
Case presentation
A 46-year-old Caucasian woman was referred to our
endocrinology clinic with a history of thyroxine-resistant
hypothyroidism and persistent hypertension. She com-
plained of mild numbness affecting her legs, but denied
weakness. Her BP was elevated to 200/100 mmHg, and
she was noted to have peripheral oedema in her shins.
Blood tests revealed a mild derangement in liver func-
tion tests and a raised platelet count. A liver ultrasound
confirmed no abnormalities. She was discharged from
the clinic on antihypertensives and an increased dose of
levothyroxine.
One year later, she was admitted with symptoms and
signs of progressive peripheral motor and sensory dis-
turbance. She had noted ascending numbness in both
legs and both hands and complained of weakness in her
lower legs with associated difficulty in walking.
Her examination revealed a BP of 205/108 mmHg,
thickening of the skin over her hands and feet with
associated peripheral oedema. There were palpable, soft
rubbery lymph nodes in the cervical and submandibular
region, and signs of a peripheral motor and sensory dis-
turbance although joint position and vibration senses
were well preserved. Ophthalmological examination
revealed bilateral papilloedema with no haemorrhages.
Initial tests (Table 1) at presentation confirmed a mild
thrombocythaemia, a mildly raised alkaline phosphatase,
moderately impaired renal function (creatinine clearance
55 ml/minute) and mild-moderate proteinuria of 0.81 g/
24 hours.
Renal ultrasound showed normal sized kidneys, and
urine analysis demonstrated 3+ blood, 1+ protein, with
dysmorphic red cells on urinary microscopy. Echocar-
diography revealed moderate left ventricular
hypertrophy.
A renal biopsy was undertaken (Figure 1), and
revealed a membranoproliferative/mesangiocapillary glo-
merulonephritis with endocapillary hypercellularity and
obliteration or narrowing of many capillary lumens.
Three out of 13 glomeruli were obsolete. Electron
microscopy showed irregular reduplication of the
Table 1 Tests at presentation
Full blood count Thrombocythaemia - Platelet count 520 × 10
9/L
Renal function: urea 8.2 mmol/L, creatinine 102
μmol/L, 24 hour urine collection - creatinine
clearance 55 ml/minute, Protein excretion 0.81 g/
24 hours
Liver function Normal - except alkaline phosphatase 149 IU/l
(normal range 38-126 IU/l)
Glucose, HbA1c - normal
Erythrocyte sedimentation rate (ESR) 19 mm/hour
Auto-antibodies antinuclear factor positive - titre 1/100 (double-
stranded DNA titre negative), anti-neutrophil




normal, Bence Jones Proteinuria - negative,
immunofixation of serum protein electrophoresis -
monoclonal band of IgA lambda
Thyroid function free thyroxine 13.9 mIU/l (normal range 9-25 mIU/l),
thyroid stimulating hormone (TSH) 6.68 mIU/l
(normal range 0.5-4.5 mIU/l), thyroid peroxidase
antibodies - within normal limits
Growth hormones, sex hormones and cortisol levels
normal
24 hour urinary catecholamines - normal
Figure 1 Renal biopsy. Periodic acid Schiff staining shows
membranoproliferative/mesangiocapillary glomerulonephritis.
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of small arteries and arterioles. Electron microscopy
identified marked subendothelial widening with a fine
granular material. IgM outlined some of the peripheral
lobules and there was very variable and mild deposition
of C3, but no IgG, IgA nor C1q deposition.
Computed tomography (CT) scans of the patient’s
chest and abdomen showed widespread but small lym-
phadenopathy in the thorax and axilla, and para-aortic
area, with splenomegaly. Subsequent cervical lymph node
biopsy showed only mild sinus histiocytosis. Trephine
bone marrow biopsy revealed histologically normal mar-
row, with normal lymphocyte subsets on phenotyping.
Biopsy of the sural nerve revealed an active neuropathy
with prominent inflammatory features. There was evi-
dence of axonal degeneration and demyelination.
A working diagnosis of POEMS syndrome was consid-
ered as the patient fulfilled most of the criteria at the
time, with the exception of a paraprotein band [2]. In
the light of the neuropathy, it was decided to initiate a
5-day course of intravenous immunoglobulins, and low-
dose steroids (oral prednisolone 10 mg/day) were also
started. Her follow-up was transferred to our hospital.
On initial presentation to us, the patient’s BP was ele-
vated (systolic BP >140 mmHg), however, following this,
her BP was better controlled with systolic values in the
range 110-120 mmHg and diastolic pressures in the
range 60-70 mmHg.
On 10 mg of prednisolone daily, her proteinuria initi-
ally rose to 1.5 g/24 hours, but settled to approximately
0.7-0.8 g/24 hours, however, her renal function contin-
ued to deteriorate (Figure 2). Nerve conduction studies
suggested a progression of her neuropathy. At this stage
(just under 2 years from presentation with nephropathy),
it was decided to add in low-dose mycophenolate mofe-
til (MMF) (250 mg twice a day) and to double the ster-
oid dose. Since then, her renal function has remained
reasonably stable, and proteinuria minimal, despite a
steady reduction in prednisolone dose to a maintenance
level of 7.5 mg/day.
There was a minor unexpected rise in her serum crea-
tinine 2 years later, which promptly reversed with a
transient rise in steroid dose to 20 mg/day. Around this
time, she also began to develop increasingly abnormal
liver function tests with rising gamma glutamyl trans-
peptidase (GT), alkaline phosphatase and alanine amino-
transferase (ALT) - which prompted a liver biopsy. This
only demonstrated nodular degenerative hyperplasia,
and interestingly, the abnormal liver tests also partially
resolved with the transient increase in steroid dose.
The neuropathy appears to have stabilised, and the
patient remains well 6 years after initial presentation,
with stable moderate renal impairment, mild proteinuria
and stable moderately impaired liver tests.
Recently, using immunofixation, we have demon-
strated a monoclonal band of IgA lambda; our patient
finally fulfilling the criteria for POEMS syndrome.
Discussion
A logical approach to the general treatment of POEMS
is defined by the presence or absence of a dominant
sclerotic plasmacytoma; in which case the first-line ther-
apy should include radiation to the lesion. Patients with
diffuse sclerotic lesions or absence of any bony lesion,
and patients who have not demonstrated stabilisation of
their disease by 3 to 6 months after completing radia-
tion therapy, should be considered for systemic therapy.
Treatments include corticosteroids, low-dose alkylator
therapy, and high-dose chemotherapy with peripheral
blood stem cell transplant [9].
Treatment options for the nephropathy of POEMS
syndrome are limited and based on anecdotal case
reports. Navis et al. [ 6 ]s h o w e dt h a ta2 0 - m o n t hc o u r s e
of prednisolone improved the renal function of their
patient although renal function did not return to nor-
mal. Erbslöh-Möller et al. [10] also showed that renal
function improved with methylprednisolone although it
rapidly deteriorated once steroid therapy was stopped.
Of the 52 patients reviewed by Nakamoto et al. [7],
the majority received melphalan and prednisolone ther-
apy as the baseline regimen, and occasionally additional
cytotoxic drugs and steroid pulsed therapy.
More recently, Sanada et al. [11] treated a 61-year-old
woman with POEMS syndrome characterised by
advanced renal impairment with high-dose melphalan
therapy (HDT) supported by autologous blood stem
cell transplantation (SCT), effecting a clinical remission
and striking histological resolution of renal lesions
Figure 2 Plasma creatinine and urinary protein concentration
with time. Plasma creatinine stabilises whilst urinary protein loss
drops significantly then plateaus at ~0.3 g/24 hours.
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pathic glomerulopathy, and mesangiolytic lesions) on
repeat biopsy. The treatment also markedly decreased
serum levels of vascular endothelial growth factor
(VEGF), which has been implicated in the pathogenesis
of the condition, although Nakamoto et al. have postu-
lated that raised VEGF levels may be a consequence
rather than a cause of nephropathy [7]
MMF is a non-competitive reversible inhibitor of ino-
sine 5-monophosphate dehydrogenase and is licensed in
the UK for the prophylaxis of acute renal, cardiac and
hepatic transplant rejection. Its successful use has also
been described in the treatment of other immune-
mediated conditions including improvement in neurolo-
gical symptoms in chronic inflammatory demyelinating
polyradiculopathy, and the pulmonary hypertension of
POEMS syndrome.
Our patient’s BP was only high at presentation with
nephropathy and since then has always been well con-
trolled (around 110-120/60-70 mmHg on most occa-
sions). However, despite achieving this good control, her
renal function continued to decline until 2 years later,
when specific medication (MMF) was introduced. If the
control of the BP had been the relevant intervention,
one might have expected the nephropathy to stabilise
sooner (perhaps after a lag phase of a few months), and
we postulate that the combination of MMF and steroids
is responsible for the stabilisation.
Patient’s perspective
I originally went to the GP with repeated migraines over a
short period of time. I had suffered from them for some
years before, but never with this frequency. The doctor
found my blood pressure to be extremely high and
arranged a number of blood tests which in turn revealed
abnormalities in a number of the results. An appointment
was then arranged with the endocrinologist as my thyroid
was one of the problems. I was subsequently referred to
the neurology department as by that time I was experien-
cing increasing numbness in my legs. By this time, I had
become quite disabled and had to cease driving as I had
lost the movement in one ankle. After a stay in The Royal
Free Hospital as an in-patient (the admission was delayed
for several months due to bed shortages), POEMS was
diagnosed. That was 7 years ago. The local occupational
therapist visited me at home and immediately fast tracked
an application for a Disabled Badge which has been
invaluable. The initial prescription of prednisolone gave
me the movement back in my ankle and a great improve-
ment in my energy levels after just a few weeks and I was
able to resume driving. Since then, I have been able to live
a more or less normal life with just a few restrictions due
to the numbness (neuropathy) in my legs. I cannot for
example, crouch or kneel down and if I do fall, I cannot
get up without a great deal of help. I can also only walk
short distances and only on level, smooth ground and this
is further restricted if the weather is cold. I have frequent
blood tests and have had variations in my drugs according
to the results and have had to make some adjustments to
my diet to balance out the reduced function in my kid-
neys. However, I still work part time, run a house and do
some light gardening and I generally feel well with perhaps
just more tiredness than would be normal for my age.
Conclusion
Our patient has kept well on relatively low doses of
MMF and prednisolone, with stabilisation of her
nephropathy and neuropathy. We describe an alternative
therapeutic option in patients with this serious but
poorly understood condition. We acknowledge however
that more research is required to determine whether
this treatment regimen is generally appropriate for the
nephropathy of this complex disorder.
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Written informed consent was obtained from the patient
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for review by the Editor-in-Chief of this journal.
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